Europe Dominates Bioresorbable Scaffolds Market, States GIA in Its Topical Research Report Published at MarketPublishers.com
30 Oct 2017 • by Natalie Aster
LONDON – Bioresorbable scaffolds (BRS) serve for effective acute revascularisation of coronary artery stenosis. It has been observed to be linked to low incidence rates of repeat revascularisation and major adverse cardiac events (MACE) during the early recovery process. The key benefit of the BRS is that after complete bioresorption, no extraneous body remains in the vascular wall during the long-term follow-up time, which could possibly alleviate the higher risk of stent thrombosis in the long run.
Globally, the market for bioresorbable scaffolds is thriving, driven by a high rate of prevalence of coronary artery disease and periphery arterial disease, fast expanding geriatric population, as well as longer life expectancy. Shortcomings of the current treatment modalities are also expected to boost the market growth. Meantime, a slew of technological, regulatory, cost, safety-efficacy issues could pose a challenge to the sector’s growth.
As of 2017, Europe accounts for the lion’s share of the market, which is attributed to the factors like growing regulatory approvals for stents which aim at facilitating their commercialisation and increasing R&D activities pertaining to bioresorbable stent development. APAC is distinguished for being the fastest growing bioresorbable scaffolds market.
Arterial Remodeling Technologies SA, Amaranth Medical, Abbott Laboratories, Kyoto Medical Planning Co., BIOTRONIK SE & Co. KG, and Elixir Medical Corp., among others, are the leading players in the BRS market space.
Topical research report “Bioresorbable Scaffolds: Market Research Report” drawn up by drawn up by GIA presents an exhaustive, unbiased assessment of the market on a worldwide level. The study covers annual market estimates and forecasts for key geographic markets including the USA, Europe, APAC, and RoW, for the period 2016 through 2024. A 5-year historical assessment is also provided for the markets discussed. The research delves deep into the prevalent market trends, growth restraints and drivers; uncovers relevant data on the market shares, size, demand projections. It gives an all-round product overview, includes a detailed pipeline analysis, describes the regulatory landscape, as well as reviews the recent clinical trials and approvals of products. The report tracks the recent industry activity, scrutinises the competitive scene and focuses on the 7 leading market players.
More topical market research studies by the publisher can be found at Global Industry Analysts page.